Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 484 Issue 7393, 12 April 2012

One of few surviving southern mountain yellow-legged frogs (Rana muscosa) in Kings Canyon National Park, California, where chytrid fungus has all but wiped them out. Fungal infections have caused widespread damage in crops and dramatic declines in populations of amphibians and bat species. Newly emerged pathogenic fungi have been reported in corals, bees and many plants. In a Review this week, Matthew Fisher and colleagues warn that human activity is intensifying fungal disease dispersal by modifying natural ecosystems and creating new opportunities for evolution. Unless steps are taken to reduce the risk of these infectious diseases spreading globally, the authors suggest, fungal infections will cause increasing attrition of biodiversity, with wider implications for human and ecosystem health. The authors recommendations include better monitoring of emerging diseases, stringent biosecurity controls on international trade and intensified research on the interactions between hosts, pathogens and the environment. (Photo: Joel Sartore/joelsartore.com; ALSPAC; Insert: Inset: Cohort member Amy with baby Esm /ALSPAC - Children of the 90s)

Editorial

  • An investigation by Nature shows the scale of the market for unapproved stem-cell therapies in China. Hype and unrealistic hope must not be allowed to undermine genuine promise.

    Editorial

    Advertisement

  • The plagiarism police deserve thanks for defending the honour of the PhD.

    Editorial
Top of page ⤴

World View

  • Bankers must now surrender more information on their activities. Scientists should use it to build better system-wide financial models, says John Liechty.

    • John Liechty
    World View
Top of page ⤴

Research Highlights

Top of page ⤴

Seven Days

  • The week in science: Malaria drug resistance spreading; anti-doping scientist resigns over confidentiality clauses; and the GM ‘Enviropig’ is off the menu.

    Seven Days
Top of page ⤴

News

Top of page ⤴

News Feature

  • Researchers in Britain have tracked thousands of children since their birth in the 1990s. Now the study is 21, and turning to the next generation.

    • Helen Pearson
    News Feature
Top of page ⤴

Comment

  • For a nation of its talent and education, India deserves higher scientific standing. It needs clear and honest leadership, not more money, says Gautam R. Desiraju.

    • Gautam R. Desiraju
    Comment
  • To reduce airborne soot, organics and sulphates, tailored strategies for each must be established and coal use limited, say Qiang Zhang, Kebin He and Hong Huo.

    • Qiang Zhang
    • Kebin He
    • Hong Huo
    Comment
Top of page ⤴

Books & Arts

  • Author and playwright Michael Frayn explores the wellsprings of creativity through farce, philosophy and the history of science. His eclectic output ranges from non-fiction books such as The Human Touch (2006) to plays including Noises Off (1982) and Copenhagen (1998) — which explores the 1941 meeting between quantum physicists Niels Bohr and Werner Heisenberg, with Frayn imagining their discussions on the morality of working on nuclear weapons. With his latest novel, Skios, coming out next month, he talks about determinism and the paradox of existence.

    • Richard Van Noorden
    Books & Arts
Top of page ⤴

Correspondence

Top of page ⤴

Obituary

Top of page ⤴

News & Views

  • A cutting-edge global climate model links atmospheric aerosol emissions to temperature variability in the North Atlantic Ocean, suggesting that human activity influences extreme weather events. See Letter p.228

    • Amato Evan
    News & Views
  • Transcription factors regulate the expression of genes by binding to certain DNA sequences. But the outcome can be markedly different, depending on whether the binding is stable or short-lived. See Letter p.251

    • Tommy Kaplan
    • Nir Friedman
    News & Views
  • Ageing stars produce elements vital for life and disperse them into space on stellar winds. The discovery of large dust grains in the vicinity of cool giant stars sheds light on the mechanisms that drive such winds. See Letter p.220

    • Susanne Höfner
    News & Views
  • Bacteria direct their movement in response to certain chemicals by controlling the rotation of whip-like appendages called flagella. The sensitivity of the response can be adjusted at the signal's target, the flagellar motor. See Letter p.233

    • Gerald L. Hazelbauer
    News & Views
Top of page ⤴

Review Article

Top of page ⤴

Article

  • Single atoms in optical cavities in two separate laboratories are the nodes of an elementary quantum network, in which quantum information is distributed via the controlled emission and absorption of single photons.

    • Stephan Ritter
    • Christian Nölleke
    • Gerhard Rempe
    Article
  • The crystal structure of fission yeast mitotic checkpoint complex (MCC) reveals how MCC assembly is regulated and the molecular basis of anaphase-promoting complex (APC/C) inhibition by MCC.

    • William C. H. Chao
    • Kiran Kulkarni
    • David Barford
    Article
  • The X-ray crystal structure of ultraviolet-B-sensing protein UVR8 is determined, revealing that, unlike other known photoreceptors, the chromophore is not an external cofactor but rather two amino acids.

    • Di Wu
    • Qi Hu
    • Yigong Shi
    Article
Top of page ⤴

Letter

Top of page ⤴

Technology Feature

  • As increasing numbers of protein–protein interactions are identified, researchers are finding ways to interrogate these data and understand the interactions in a relevant context.

    • Monya Baker
    Technology Feature
Top of page ⤴

Feature

Top of page ⤴

Column

  • Too many young physicists embark on projects without knowing the risks. There is a better way, argues Abraham Loeb.

    • Abraham Loeb
    Column
Top of page ⤴

Futures

Top of page ⤴

Outlook

  • Researchers have plenty of theories about what might cause multiple sclerosis. But for now, the factor that triggers the disease remains elusive.

    • Lauren Gravitz
    Outlook
  • More than 100 variations in the genome have been linked to multiple sclerosis. Researchers are now trying to find the overlap with other auto-immune conditions, and understand how environmental factors interact with genes to trigger disease.

    • Virginia Hughes
    Outlook
  • For decades, drugs have barely managed to slow the progression of multiple sclerosis. Therapies are now emerging that may even help to reverse the disease — but are they worth the risk?

    • Duncan Graham-Rowe
    Outlook
  • Researchers are still a long way from using stem cells to halt the decline caused by multiple sclerosis and to restore patients' health. But they are following some promising trails.

    • Michael Eisenstein
    Outlook
  • A slew of new data suggests that it is time to rethink and reclassify autoimmune disease, says David A. Hafler.

    • David A. Hafler
    Outlook
  • Technologies that better reveal the insidious progression of multiple sclerosis could aid the search for treatments.

    • Cynthia Graber
    Outlook
  • Population and genetic studies are confirming the link between multiple sclerosis and vitamin D, says Richard Ransohoff.

    • Richard M. Ransohoff
    Outlook
  • Despite some outstanding drug-development successes, the mouse version of multiple sclerosis has been worryingly unreliable at screening human treatments.

    • Jocelyn Rice
    Outlook
  • Most new treatments for multiple sclerosis are for patients with the relapsing–remitting form of the disease. Those with the more advanced, progressive type are being left behind.

    • Courtney Humphries
    Outlook
  • Worms? Stents? Bee stings? Patients with multiple sclerosis who exhaust conventional therapies are turning in desperation to unproven approaches.

    • Jennifer Berglund
    Outlook
Top of page ⤴

Nature Outlook

  • Successfully treating multiple sclerosis (MS) will require drugs that can reverse nerve damage and repair the myelin sheaths that coat them. Yet until now the best medicines have only managed to slow disease progression. Nature Outlook: Multiple sclerosis covers the latest research into how MS starts, and explores new ways to diagnose and treat it.

    Nature Outlook
Top of page ⤴
Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links